MIRIAM TAVAKOLY: Open Payments
NPI 1710247192 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 22 payments from 10 companies in 2025. Trend: 2023 $694 · 2024 $1,159 · 2025 $1,054
Food & beverage: $1,054
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $371 |
| GENZYME CORPORATION | 1 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Kowa Pharmaceuticals America, Inc. | 5 | $114 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| Lilly USA, LLC | 2 | $54 |
| PFIZER INC. | 2 | $50 |
| ABBVIE INC. | 2 | $42 |
| Eisai Inc. | 1 | $32 |
| KYOWA KIRIN, INC. | 1 | $27 |
Products named: JARDIANCE, DUPIXENT, FASENRA, BREZTRI, AIRSUPRA, ZORYVE, TRELEGY ELLIPTA, Leqembi.
Industry payments across NY — which companies pay providers there.
